Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
Authors
Keywords
-
Journal
Autophagy
Volume 8, Issue 4, Pages 609-622
Publisher
Informa UK Limited
Online
2012-06-12
DOI
10.4161/auto.19048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection
- (2011) Yi Wen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Hsp70 by Methylene Blue Affects Signaling Protein Function and Ubiquitination and Modulates Polyglutamine Protein Degradation
- (2010) Adrienne M. Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GSK-3β promotes cell survival by modulating Bif-1-dependent autophagy and cell death
- (2010) Jun Yang et al. JOURNAL OF CELL SCIENCE
- Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
- (2010) John C O'Leary et al. Molecular Neurodegeneration
- Generation of Tau Aggregates and Clearance by Autophagy in an Inducible Cell Model of Tauopathy
- (2010) Y. Wang et al. Neurodegenerative Diseases
- A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model
- (2010) A. S. Tsvetkov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3
- (2009) Fiona M. Menzies et al. BRAIN
- Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability
- (2009) U. K. Jinwal et al. JOURNAL OF NEUROSCIENCE
- Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in -Synuclein Models of Parkinson's and Lewy Body Diseases
- (2009) B. Spencer et al. JOURNAL OF NEUROSCIENCE
- Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy
- (2009) C. Wischik et al. Journal of Nutrition Health & Aging
- Striatal neuroprotection with methylene blue
- (2009) J.C. Rojas et al. NEUROSCIENCE
- Methylene Blue Provides Behavioral and Metabolic Neuroprotection Against Optic Neuropathy
- (2009) Julio C. Rojas et al. NEUROTOXICITY RESEARCH
- O1-06-04: Methylthioninium chloride (MTC) acts as a Tau aggregation inhibitor (TAI) in a cellular model and reverses Tau pathology in transgenic mouse models of Alzheimer's disease
- (2008) Charles Harrington et al. Alzheimers & Dementia
- O3-04-07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks
- (2008) Claude M. Wischik et al. Alzheimers & Dementia
- Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression
- (2008) Tadanori Hamano et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Beclin 1 Forms Two Distinct Phosphatidylinositol 3-Kinase Complexes with Mammalian Atg14 and UVRAG
- (2008) Eisuke Itakura et al. MOLECULAR BIOLOGY OF THE CELL
- Animal models of Alzheimer's disease and frontotemporal dementia
- (2008) Jürgen Götz et al. NATURE REVIEWS NEUROSCIENCE
- Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways
- (2007) Hani Atamna et al. FASEB JOURNAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started